blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3904340

EP3904340 - SYNTHESIS METHOD FOR HALOFUGINONE AND INTERMEDIATE THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.05.2024
Database last updated on 30.09.2024
FormerThe patent has been granted
Status updated on  02.06.2023
FormerGrant of patent is intended
Status updated on  08.03.2023
FormerRequest for examination was made
Status updated on  01.10.2021
FormerThe international publication has been made
Status updated on  04.07.2020
Most recent event   Tooltip19.07.2024Lapse of the patent in a contracting state
New state(s): CH		published on 21.08.2024  [2024/34]
Applicant(s)For all designated states
Launch-Pharma Technologies, Ltd.
5th Floor, Building D
188 Kaiyuan Avenue The Science Park of Guangzhou
High-Tech Industrial Development Zone
Guangzhou, Guangdong 510530 / CN
[2021/44]
Inventor(s)01 / JIN, Yehua
5th Floor, Building D, 188 Kaiyuan Avenue, The Science Park of Guangzhou
High-Tech Industrial Development Zone
Guangzhou, Guangdong 510530 / CN
02 / QIU, Fayang
5th Floor, Building D, 188 Kaiyuan Avenue, The Science Park of Guangzhou
High-Tech Industrial Development Zone
Guangzhou, Guangdong 510530 / CN
03 / XU, Hua
5th Floor, Building D, 188 Kaiyuan Avenue, The Science Park of Guangzhou
High-Tech Industrial Development Zone
Guangzhou, Guangdong 510530 / CN
04 / YIN, Wenhao
5th Floor, Building D, 188 Kaiyuan Avenue, The Science Park of Guangzhou
High-Tech Industrial Development Zone
Guangzhou, Guangdong 510530 / CN
 [2023/27]
Former [2021/44]01 / JIN, Yehua
Guangzhou, Guangdong 510530 / CN
02 / QIU, Fayang
Guangzhou, Guangdong 510530 / CN
03 / XU, Hua
Guangzhou, Guangdong 510530 / CN
04 / YIN, Wenhao
Guangzhou, Guangdong 510530 / CN
Representative(s)Haseltine Lake Kempner LLP
One Portwall Square
Portwall Lane
Bristol BS1 6BH / GB
[2023/27]
Former [2021/44]Haseltine Lake Kempner LLP
Redcliff Quay
120 Redcliff Street
Bristol BS1 6HU / GB
Application number, filing date19902141.118.09.2019
[2021/44]
WO2019CN106485
Priority number, dateCN20181162609528.12.2018         Original published format: CN201811626095
CN2019109047330.01.2019         Original published format: CN201910090473
[2021/44]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020134212
Date:02.07.2020
Language:ZH
[2020/27]
Type: A1 Application with search report 
No.:EP3904340
Date:03.11.2021
Language:EN
[2021/44]
Type: B1 Patent specification 
No.:EP3904340
Date:05.07.2023
Language:EN
[2023/27]
Search report(s)International search report - published on:CN02.07.2020
(Supplementary) European search report - dispatched on:EP05.10.2022
ClassificationIPC:C07D211/42, C07D401/06
[2021/44]
CPC:
C07C69/92 (EP); C07D211/42 (EP,US); B01J31/0239 (US);
C07C69/76 (EP); C07D401/06 (EP,US); C07B2200/07 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/44]  
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:SYNTHESEVERFAHREN FÜR HALOFUGINON UND ZWISCHENPRODUKT DAVON[2021/44]
English:SYNTHESIS METHOD FOR HALOFUGINONE AND INTERMEDIATE THEREOF[2021/44]
French:PROCÉDÉS DE SYNTHÈSE D'UNE HALOFUGINONE ET D'UN INTERMÉDIAIRE DE CELLE-CI[2021/44]
Entry into regional phase27.07.2021Translation filed 
27.07.2021National basic fee paid 
27.07.2021Search fee paid 
27.07.2021Designation fee(s) paid 
27.07.2021Examination fee paid 
Examination procedure27.07.2021Examination requested  [2021/44]
25.11.2022Amendment by applicant (claims and/or description)
09.03.2023Communication of intention to grant the patent
25.05.2023Fee for grant paid
25.05.2023Fee for publishing/printing paid
25.05.2023Receipt of the translation of the claim(s)
Opposition(s)08.04.2024No opposition filed within time limit [2024/24]
Fees paidRenewal fee
27.09.2021Renewal fee patent year 03
27.09.2022Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCZ05.07.2023
ES05.07.2023
HR05.07.2023
MC05.07.2023
PL05.07.2023
RO05.07.2023
RS05.07.2023
SK05.07.2023
SM05.07.2023
IE18.09.2023
CH30.09.2023
GB05.10.2023
NO05.10.2023
GR06.10.2023
IS05.11.2023
[2024/34]
Former [2024/33]CZ05.07.2023
ES05.07.2023
HR05.07.2023
MC05.07.2023
PL05.07.2023
RO05.07.2023
RS05.07.2023
SK05.07.2023
SM05.07.2023
IE18.09.2023
GB05.10.2023
NO05.10.2023
GR06.10.2023
IS05.11.2023
Former [2024/28]CZ05.07.2023
ES05.07.2023
HR05.07.2023
MC05.07.2023
PL05.07.2023
RO05.07.2023
RS05.07.2023
SK05.07.2023
SM05.07.2023
NO05.10.2023
GR06.10.2023
IS05.11.2023
Former [2024/23]CZ05.07.2023
ES05.07.2023
HR05.07.2023
PL05.07.2023
RO05.07.2023
RS05.07.2023
SK05.07.2023
SM05.07.2023
NO05.10.2023
GR06.10.2023
IS05.11.2023
Former [2024/20]ES05.07.2023
HR05.07.2023
PL05.07.2023
RS05.07.2023
SM05.07.2023
NO05.10.2023
GR06.10.2023
IS05.11.2023
Former [2024/11]ES05.07.2023
HR05.07.2023
PL05.07.2023
RS05.07.2023
NO05.10.2023
GR06.10.2023
IS05.11.2023
Former [2024/09]ES05.07.2023
NO05.10.2023
GR06.10.2023
IS05.11.2023
Former [2024/08]NO05.10.2023
GR06.10.2023
Documents cited:Search[A]CN101987843  (UNIV NANKAI, et al) [A] 1-15 * claim - *;
 [A]CN103275063  (CHONGQING WEIPENG PHARMACEUTICAL CO LTD) [A] 1-15* claim - *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.